Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Hires at Cepheid; Qiagen Names CMO; Lumora Appoints Commercial Director


Cepheid said this week that John Reed has joined the company as vice president of manufacturing.

Cepheid CEO John Bishop disclosed the new hire during a conference call this week recapping the company's fourth-quarter and full-year 2012 financial results. Bishop said that Reed joins Cepheid from Advantis Medical Systems, where he served as chief operating officer for the past five years. Prior to that he held several executive roles with Agilent and Applied Biosystems, now part of Life Technologies.

Bishop also during the call noted that the company recently hired Philippe Jacon as head of international commercial operations. Jacon will be responsible for commercial and high-burden developing country sales worldwide except North America. Cepheid originally disclosed that it had hired Jacon last week when it said that it had terminated the employment of Nicolaas Arnold, the company's former executive vice president of worldwide commercial operations (PCR Insider, 1/17/2013).

Qiagen said this week that Tadd Lazarus has joined the company as chief medical officer.

Lazarus joins Qiagen from Gen-Probe, where he was chief medical officer and vice president of clinical affairs. He will be responsible for Qiagen's overall medical strategy, including the evaluation and advancement of the company's diagnostic assay portfolio, and the clinical evaluation of new diagnostic tests. Lazarus will be based at Qiagen's site in Germantown, Md., and will report to Helge Lubenow, Qiagen's senior vice president and head of the molecular diagnostics business area.

Lumora this week announced the appointment of Hayden Jeffreys as commercial director.

Jeffreys joins Lumora from Lab21, where he was divisional director of diagnostic products. Prior to Lab21, Jeffrys held positions at Invitron, Gen-Probe, and Molecular Light Technology.

Jeffreys will help Lumora further commercialize its molecular testing technologies, including its bioluminescent assay in real time, or BART, which has been licensed to 3M for in vitro molecular testing in food and beverages as part of the 3M Molecular Detection System.